ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PIA Vivione Biosciences, Inc.

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Vivione Biosciences, Inc. TSXV:PIA TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

PACEpartners Inc. Retains Investor Relations Firm and Settles Debt

30/04/2013 1:37am

Marketwired Canada


NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN THE
UNITED STATES 


PACEpartners Inc. (TSX VENTURE:PIA) (PACEpartners) is pleased to announce that
it has retained Stone Communications Services Limited (SCS) of Toronto, Ontario
(the Agreement) to perform Investor Relations Services on behalf of
PACEpartners.  


SCS specializes in the execution of tailored, strategic communication programs
for emerging companies and will introduce PACEpartners to SCS's network of
brokers, analyst and portfolio managers. SCS is a wholly owned subsidiary of
Stone Investment Group. 


The Agreement has a term of one year, pursuant to which SCS will provide
investor relations services to PACEpartners including the development of
investor relations strategies relating to advertising programs and investor
awareness and fostering broker and analyst interest in PACEpartners' activities.



Subject to the approval of the TSX Venture Exchange, as compensation for its
services SCS will receive a retainer fee of $4,000 per month, reimbursement for
related expenses and an aggregate of 300,000 options (the Options) to purchase
common shares in the capital of PACEpartners pursuant to the terms of
PACEpartners' stock option plan. 75,000 Options will vest every three months,
with all Options having an exercise price of $0.25. Other than the Options, SCS
has no interest, directly or indirectly, in PACEpartners or any right or intent
to acquire such an interest. 


Kevin Kuykendall, Chief Executive Officer of PACEpartners, stated "I am very
pleased to be working with SCS as their knowledge of the investment industry
will be invaluable in the next chapter of our company's evolution."


Shares for Debt 

PACEpartners has agreed to settle debt in the aggregate of $84,769 (including
accrued interest) owing to two insiders of PACEpartners by repaying half of the
aggregate debt in cash and by issuing the two insiders an aggregate of 169,538
Class A Common Shares at a deemed price of $0.25 per share, which was the
closing price of the Class A Common Shares on the TSX Venture Exchange on April
26, 2013. The transactions contemplated under the settlement agreements are
subject to certain conditions including, but not limited to, the approval of the
TSX Venture Exchange.


Cautionary Statements 

This news release contains "forward-looking information" within the meaning of
applicable securities laws relating to the business of PACEpartners. Readers are
cautioned to not place undue reliance on forward-looking information. The use of
any of the words "could", "expect", "believe", "will", "projected", "estimated"
and similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking information and are
based on PACEpartners' current belief or assumptions as to the outcome and
timing of such future events. Actual results and developments may differ
materially from those contemplated by this forward-looking information due to,
among other things, the inability of PACEpartners to obtain regulatory
approvals, the success of the strategic communication programs and the success
of the commercialization of the RAPID-B diagnostic system. The reader is
cautioned not to place undue reliance on this forward-looking information. 


The securities mentioned herein have not been and will not be registered under
the United States Securities Act of 1933, as amended, or the securities laws of
any state, and may not be offered or sold in the United States absent
registration or an applicable exemption from registration requirements. This
press release does not constitute an offer to sell or the solicitation of any
offer to buy these securities in any jurisdiction. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
PACEpartners Inc.
Kevin Kuykendall
Chief Executive Officer
(214) 886-5733


Stone Communication Services Limited
Jason Stone
Managing Director
(416) 867-2533
jasons@stoneco.com

1 Year Vivione Biosciences, Inc. Chart

1 Year Vivione Biosciences, Inc. Chart

1 Month Vivione Biosciences, Inc. Chart

1 Month Vivione Biosciences, Inc. Chart